125 related articles for article (PubMed ID: 29275643)
1. Gastric cancer in Latin America.
Ruíz-García E; Guadarrama-Orozco J; Vidal-Millán S; Lino-Silva LS; López-Camarillo C; Astudillo-de la Vega H
Scand J Gastroenterol; 2018 Feb; 53(2):124-129. PubMed ID: 29275643
[TBL] [Abstract][Full Text] [Related]
2. Role of gene polymorphisms in gastric cancer and its precursor lesions: current knowledge and perspectives in Latin American countries.
Chiurillo MA
World J Gastroenterol; 2014 Apr; 20(16):4503-15. PubMed ID: 24782603
[TBL] [Abstract][Full Text] [Related]
3. Association of a distinctive strain of Epstein-Barr virus with gastric cancer.
Corvalan A; Ding S; Koriyama C; Carrascal E; Carrasquilla G; Backhouse C; Urzua L; Argandoña J; Palma M; Eizuru Y; Akiba S
Int J Cancer; 2006 Apr; 118(7):1736-42. PubMed ID: 16217758
[TBL] [Abstract][Full Text] [Related]
4. Risk factors for gastric cancer in Latin America: a meta-analysis.
Bonequi P; Meneses-González F; Correa P; Rabkin CS; Camargo MC
Cancer Causes Control; 2013 Feb; 24(2):217-31. PubMed ID: 23224270
[TBL] [Abstract][Full Text] [Related]
5. Molecular epidemiology of gastric cancer.
Starzyńska T
Dig Dis; 2007; 25(3):222-4. PubMed ID: 17827944
[TBL] [Abstract][Full Text] [Related]
6. Environmental factors related to gastric cancer associated with Epstein-Barr virus in Colombia.
Campos FI; Koriyama C; Akiba S; Carrasquilla G; Serra M; Carrascal E; Itoh T; Minakami Y; Eizuru Y
Asian Pac J Cancer Prev; 2006; 7(4):633-7. PubMed ID: 17250442
[TBL] [Abstract][Full Text] [Related]
7. TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives.
de Moura Gallo CV; Azevedo E Silva Mendonça G; de Moraes E; Olivier M; Hainaut P
Mutat Res; 2005 May; 589(3):192-207. PubMed ID: 15878142
[TBL] [Abstract][Full Text] [Related]
8. Characteristics of gastric cancer around the world.
López MJ; Carbajal J; Alfaro AL; Saravia LG; Zanabria D; Araujo JM; Quispe L; Zevallos A; Buleje JL; Cho CE; Sarmiento M; Pinto JA; Fajardo W
Crit Rev Oncol Hematol; 2023 Jan; 181():103841. PubMed ID: 36240980
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus-associated gastric carcinoma: Evidence of age-dependence among a Mexican population.
Herrera-Goepfert R; Akiba S; Koriyama C; Ding S; Reyes E; Itoh T; Minakami Y; Eizuru Y
World J Gastroenterol; 2005 Oct; 11(39):6096-103. PubMed ID: 16273633
[TBL] [Abstract][Full Text] [Related]
10. Gastric cancer in Africa: what do we know about incidence and risk factors?
Asombang AW; Kelly P
Trans R Soc Trop Med Hyg; 2012 Feb; 106(2):69-74. PubMed ID: 22136952
[TBL] [Abstract][Full Text] [Related]
11. Clinicopathological features of 22C3 PD-L1 expression with mismatch repair, Epstein-Barr virus status, and cancer genome alterations in metastatic gastric cancer.
Kawazoe A; Shitara K; Kuboki Y; Bando H; Kojima T; Yoshino T; Ohtsu A; Ochiai A; Togashi Y; Nishikawa H; Doi T; Kuwata T
Gastric Cancer; 2019 Jan; 22(1):69-76. PubMed ID: 29859006
[TBL] [Abstract][Full Text] [Related]
12. Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China.
Chen JN; Ding YG; Feng ZY; Li HG; He D; Du H; Wu B; Shao CK
J Med Virol; 2010 Apr; 82(4):658-67. PubMed ID: 20166192
[TBL] [Abstract][Full Text] [Related]
13. Prevalence and characteristics of Epstein-Barr virus-associated gastric cancer in Iran.
Faghihloo E; Saremi MR; Mahabadi M; Akbari H; Saberfar E
Arch Iran Med; 2014 Nov; 17(11):767-70. PubMed ID: 25365618
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia in Epstein-Barr virus-associated and Epstein-Barr virus-negative gastric cancer.
Zhang Y; Chen JN; Dong M; Zhang ZG; Zhang YW; Wu JY; Du H; Li HG; Huang Y; Shao CK
Hum Pathol; 2017 May; 63():128-138. PubMed ID: 28300576
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus-associated gastric carcinoma in Lima, Peru.
Yoshiwara E; Koriyama C; Akiba S; Itoh T; Minakami Y; Chirinos JL; Watanabe J; Takano J; Miyagui J; Hidalgo H; Chacon P; Linares V; Eizuru Y
J Exp Clin Cancer Res; 2005 Mar; 24(1):49-54. PubMed ID: 15943031
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus-driven promoter hypermethylated genes in gastric cancer.
Yu J; To KF; Liang QY
Hong Kong Med J; 2017 Aug; 23 Suppl 5(4):17-22. PubMed ID: 28943520
[No Abstract] [Full Text] [Related]
17. Clinicopathological and prognostic features of Epstein-Barr virus infection, microsatellite instability, and PD-L1 expression in gastric cancer.
Pereira MA; Ramos MFKP; Faraj SF; Dias AR; Yagi OK; Zilberstein B; Cecconello I; Alves VAF; de Mello ES; Ribeiro U
J Surg Oncol; 2018 Apr; 117(5):829-839. PubMed ID: 29534305
[TBL] [Abstract][Full Text] [Related]
18. The utility of serologic tests as biomarkers for Helicobacter pylori-associated precancerous lesions and gastric cancer varies between Latin American countries.
Flores-Luna L; Camorlinga-Ponce M; Hernandez-Suarez G; Kasamatsu E; Martínez ME; Murillo R; Lazcano E; Torres J
Cancer Causes Control; 2013 Feb; 24(2):241-8. PubMed ID: 23184121
[TBL] [Abstract][Full Text] [Related]
19. Recent patterns in gastric cancer: a global overview.
Bertuccio P; Chatenoud L; Levi F; Praud D; Ferlay J; Negri E; Malvezzi M; La Vecchia C
Int J Cancer; 2009 Aug; 125(3):666-73. PubMed ID: 19382179
[TBL] [Abstract][Full Text] [Related]
20. Gene-diet interactions in gastric cancer risk: a systematic review.
Kim J; Cho YA; Choi WJ; Jeong SH
World J Gastroenterol; 2014 Jul; 20(28):9600-10. PubMed ID: 25071358
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
